ROCKVILLE, Md., Jan. 01, 2024 MaxCyte, Inc., , a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of.
ROCKVILLE, Md., Jan. 01, 2024 (GLOBE NEWSWIRE) MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and